AML Antigen Study Revises U5 Surface Binding Model

Company Amsterdam UMC (academic) Event Type Peer-reviewed publication Modality Target validation (antibody and CAR binder design) Asset U5 snRNP200 surface antigen model Target U5 snRNP200; FcγRIIa; heparan sulfate Disease Area Acute myeloid leukemia Summary An online-first, peer-reviewed Scientific Reports paper dated 27 October revises how…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *